CASP3 and amyotrophic lateral sclerosis: So far, several peptide inhibitors of caspase-3 have been reported [17-20], some of which were effective in animal models of amyotrophic lateral sclerosis (ALS) [21], sepsis [22], and hypoxic-ischemic brain injury [23].